OptimizeRx Corporation (NASDAQ:OPRX) Q3 2023 Earnings Call Transcript

They also include the management’s expectations for the rest of the year and adoption of the Company’s digital health platform. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events or otherwise. Forward-looking statements are inherently subjects to risk and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth-in contemplated by or underlying these forward looking statements. The risks and uncertainties to which forward-looking statements are subject to include, but are not limited to, the effects of government regulations, competition and other material risk. Risk and uncertainties to which forward looking statements are subject, two could affect business and financial results are included in the company’s annual report on Form 10-K for the quarter ended 31 December 2022.

This form is available on the company’s website and on the SEC website at sec.gov. Before we end today’s conference, I would like to remind everyone that this call will be available for replay via webcast only, starting later this evening, running through for a year. Please refer to today’s press release for replay instructions available via the company’s website at www.optimizerx.com. Thank you for joining us today. This concludes today’s conference call. You may now disconnect your lines.